Functional treatment of temporal bone chondroblastoma: retrospective analysis of 3 cases.


Journal

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 02 05 2020
accepted: 08 07 2020
pubmed: 15 7 2020
medline: 29 4 2021
entrez: 15 7 2020
Statut: ppublish

Résumé

To describe and analyse functional treatment of temporal bone chondroblastoma (TBCh). From January 2000 to June 2019, at the Department of Otorhinolaryngology, Hôpital Lariboisière, Paris, France, patients with TBCh were enrolled in this study. All cases routinely performed pre-operatory work-up including evaluation of performance status, audio-vestibular function test, ear endoscopy, contrasted CT scan and MRI of head and neck region; in one case we also performed an angio-CT scan. All patients underwent resection of the tumour with a "functional" approach RESULTS: Three male patients (mean age 46,6 years)-two primary tumours and one recurrence-were treated. In all three cases the tumour invaded the middle ear with a variable degree of hearing loss and infiltration of temporal bone structures. All surgeries were performed with a microscopic approach associated with open/endoscopic approach when necessary. Inner ear and facial nerve were speared in all cases and the TMJ was partially resected in 2 cases due to its moderate involvement. At present, after a mean follow-up of 103 months (range 40-225 months), only one case presented recurrence which has been successfully treated with radiotherapy. Our results of treatment suggest that functional surgery can be relevant in the management of TBCh since it is focused on both treatment of this pathology and maintenance of a good quality of life.

Identifiants

pubmed: 32661717
doi: 10.1007/s00405-020-06203-4
pii: 10.1007/s00405-020-06203-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1271-1276

Références

Reid LB, Wong DS, Lyons B (2011) Chondroblastoma of the temporal bone: a case series, review, and suggested management strategy. Skull Base Rep 1:71–82. https://doi.org/10.1055/s-0031-1284217
doi: 10.1055/s-0031-1284217 pubmed: 23984206 pmcid: 3743598
Vandenberg HJ Jr, Coley BL (1950) Primary tumors of the cranial bones. Surg Gynecol Obstet 90:602–612
pubmed: 15418430
Politi M, Consolo U, Panziera G, Capelli P, Bonetti F (1991) Chondroblastoma of the temporal bone. Case report J Craniomaxillofac Surg 19:319–322
doi: 10.1016/S1010-5182(05)80340-3
Kurt AM, Unni KK, Sim FH, McLeod RA (1989) Chondroblastoma of bone. Hum Pathol 20:965–976
doi: 10.1016/0046-8177(89)90268-2
Dahlin DC, Ivins JC (1972) Benign chondroblastoma. A study of 125 cases. Cancer 30:401–413
doi: 10.1002/1097-0142(197208)30:2<401::AID-CNCR2820300216>3.0.CO;2-B
Dran G, Niesar E, Vandenbos F, Noel G, Paquis P, Lonjon M (2007) Chondroblastoma of the apex portion of petrousal bone. Childs Nerv Syst 23:231–235. https://doi.org/10.1007/s00381-006-0201-9
doi: 10.1007/s00381-006-0201-9 pubmed: 17115228
Huang L, Cheng YY, Chow LT, Zheng MH, Kumta SM (2003) Receptor activator of NF-kappaB ligand (RANKL) is expressed in chondroblastoma: possible involvement in osteoclastic giant cell recruitment. Mol Pathol 56:116–120. https://doi.org/10.1136/mp.56.2.116
doi: 10.1136/mp.56.2.116 pubmed: 12665629 pmcid: 1187303
Calvert N, Wood D (2017) Use of denosumab in recurrent chondroblastoma of the squamous temporal bone: a case report. Clin Case Rep 5:411–413. https://doi.org/10.1002/ccr3.838
doi: 10.1002/ccr3.838 pubmed: 28396758 pmcid: 5378851
Yokoyama J, Yoshimoto H, Ito S et al (2011) Successful function-preserving therapy for chondroblastoma of the temporal bone involving the temporomandibular joint. Case Rep Oncol 4:74–81. https://doi.org/10.1159/000324640
doi: 10.1159/000324640 pubmed: 21475594 pmcid: 3072183
Moon IS, Kim J, Lee HK, Lee WS (2008) Surgical treatment and outcomes of temporal bone chondroblastoma. Eur Arch Otorhinolaryngol 265:1447–1454. https://doi.org/10.1007/s00405-008-0660-6
doi: 10.1007/s00405-008-0660-6 pubmed: 18401591
Hu K, Persky MS (2016) Treatment of head and neck paragangliomas. Cancer Control 23:228–241. https://doi.org/10.1177/107327481602300306
doi: 10.1177/107327481602300306 pubmed: 27556663

Auteurs

Alessandro Vinciguerra (A)

Department of Surgical Sciences, Division of Otolaryngology, IRCCS San Raffaele Hospital, Vita-Salute University, Milan, Italy. vinciguerra.alessandro@hsr.it.
Otolaryngology Department, San Raffaele Hospital, Via Olgettina, 68, 20100, Milan, Italy. vinciguerra.alessandro@hsr.it.

Benjamin Verillaud (B)

Department of Otorhinolaryngology, Hôpital Lariboisière, Assistance Publique - Hôpitaux de Paris, Université de Paris, Inserm U1141, 2, rue Ambroise-Paré, 75010, Paris, France.

Michaël Eliezer (M)

Department of Neuroradiology, Hôpital Lariboisière, Assistance Publique - Hôpitaux de Paris, Université de Paris, 2, rue Ambroise-Paré, 75010, Paris, France.

Rachid Kaci (R)

Department of Pathology, Hôpital Lariboisière, Assistance Publique - Hôpitaux de Paris, 2, rue Ambroise-Paré, 75010, Paris, France.

Romain Kania (R)

Department of Otorhinolaryngology, Hôpital Lariboisière, Assistance Publique - Hôpitaux de Paris, Université de Paris, Inserm U1141, 2, rue Ambroise-Paré, 75010, Paris, France.

Philippe Herman (P)

Department of Otorhinolaryngology, Hôpital Lariboisière, Assistance Publique - Hôpitaux de Paris, Université de Paris, Inserm U1141, 2, rue Ambroise-Paré, 75010, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH